RePub Publications from Erasmus University, Rotterdam
-
Predictive Impact of Urokinase-Type Plasminogen Activator: Plasminogen Activator Inhibitor Type-1 Complex on the Efficacy of Adjuvant Systemic Therapy in Primary Breast Cancer Article
Cancer Research, 64(2), 659-664.P. Manders (Peggy), V.C.G. Tjan-Heijnen (Vivianne), P.N. Span (Paul), N. Grebenchtchikov (Nicolai), J.A. Foekens (John), L.V. Beex (Louk) and C.G.J. Sweep
January 2004 -
Receptor activation and 2 distinct COOH-terminal motifs control G-CSF receptor distribution and internalization kinetics Article
Blood, 103(2), 571-579.L.H.J. Aarts (Bart), O. Roovers (Onno), A.C. Ward (Alister) and I.P. Touw (Ivo)
January 2004 -
MIB-1 (KI-67) Proliferation Index and Cyclin-Dependent Kinase Inhibitor p27Kip1 Protein Expression in Nephroblastoma Article
Clinical Cancer Research, 10(2), 591-597.M.A.I. Ghanem (Mazen), Th.H. van der Kwast (Theo), M.K. Sudaryo, R.B. Mathoera (Rejiv), M.M. van den Heuvel-Eibrink (Marry), A.A. Al-Doray, R.J.M. Nijman (Rien) and G.J. van Steenbrugge (Gert Jan)
January 2004 -
Influence of Promoter Variants of Interleukin-10, Interleukin-9, and Tumor Necrosis Factor-α Genes on Respiratory Syncytial Virus Bronchiolitis Article
The Journal of Infectious Diseases, 189(2), 239-247.B. Hoebee (Barbara), L.J. Bont (Louis), E. Rietveld (Edwin), M. van Oosten (Marijke), H.M. Hodemaekers (Hennie), N.J.D. Nagelkerke (Nico), H.J. Neijens (Herman), J.L.L. Kimpen (Jan) and T.G. Kimman
January 2004 -
Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometry Article
Analytical Biochemistry, 324(2), 276-284.S.D. Baker (Sharyn), M. Zhao (Meina), P. He (Peijian), M.A. Carducci, J. Verweij (Jaap) and A. Sparreboom (Alex)
January 2004 -
Corporate Finance In Europe Confronting Theory With Practice Research Paper
(no. ERS-2004-002-F&A) ERIM Report Series Research in ManagementJanuary 2004
-
Mobile operators as banks or vice-versa? and: the challenges of Mobile channels for banks Research Paper
(no. ERS-2004-015-LIS) ERIM Report Series Research in ManagementJanuary 2004
-
Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: Randomised trial Article
The Lancet, 363(9404), 192-196.R. van Koningsveld (Rinske), P.I.M. Schmitz (Paul), F.G.A. van der Meché (Frans), L.H. Visser (Leendert), J. Meulstee (Jan) and P.A. van Doorn (Pieter)
January 2004